REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N70 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N70 Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

MUP Apteka N70 is based in Russia, with the head office in Samara Oblast. It operates in the Pharmacies and Drug Stores industry. MUP Apteka N70 was incorporated on February 08, 2003. There was a net sales revenue increase of 9.25% reported in MUP Apteka N70’s latest financial highlights for 2022. Its’ total assets recorded a negative growth of 0.15%. The net profit margin of MUP Apteka N70 decreased by 0.58% in 2022.

Headquarters
Shigony, Sovetskaya, 143
Samara Oblast; Samara Oblast; Postal Code: 446720

Contact Details: Purchase the MUP Apteka N70 report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Apteka N70 report to view the information.
Registered Capital:
Purchase the MUP Apteka N70 report to view the information.
Incorporation Date:
February 08, 2003
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Apteka N70 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
9.25%
Total operating revenue
9.25%
Operating profit (EBIT)
-34.38%
Net Profit (Loss) for the Period
-80.14%
Total assets
-0.15%
Total equity
-14.91%
Operating Profit Margin (ROS)
-0.85%
Net Profit Margin
-0.58%
Return on Equity (ROE)
-9.25%
Quick Ratio
-1.05%
Cash Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?